Celecoxib API Market Size was valued at USD 58.9 Mn in 2023 and is predicted to reach USD 87.0 Mn by 2031 at a 5.1% CAGR during the forecast period for 2024-2031.
Celecoxib API marketing focuses on the production, distribution, and retail sale of celecoxib as a component in various pharmaceutical products. In addition to relieving inflammation and pain, nonsteroidal anti-inflammatory medications such as celecoxib can also lower body temperature. The rising demand for celecoxib API in pharmaceutical and laboratory applications worldwide is driving the market's expansion. The research delves into the profitable prospects in the celecoxib API market. Furthermore, the global celecoxib API market is experiencing strong growth due to numerous key factors, such as reduced inflammation and pain; there is an increasing demand for high-quality active pharmaceutical components like celecoxib. There has been a lot of investment from pharmaceutical companies in developing effective therapies for conditions like arthritis, which has led to a strong demand for celecoxib. Sustainable and ecologically friendly production practices are also becoming more important in the global celecoxib API market.
However, the market growth needs to be improved by a complex regulatory landscape encompassing pharmaceutical manufacture, necessitating extensive testing, quality assurance, and compliance paperwork, resulting in heightened production expenses and delays in product launch, which slows down the celecoxib API market growth. In addition, the celecoxib API market is being significantly influenced by research in pharmaceutical production and technical improvements. In order to create celecoxib with a high level of purity, manufacturers and researchers are putting money into state-of-the-art technology and new methods, providing opportunities for market growth in the coming years.
The celecoxib API market is segmented based on type and application. Based on type, the market is segmented into standard-grade celecoxib API and micronized celecoxib API. By application, the market is segmented into pharmaceutical and laboratory.
The standard-grade celecoxib API celecoxib API market is expected to hold a major global market share in 2023. This is propelled by the demonstrated safety and efficaciousness in the management of various ailments, including pain and arthritis. Celecoxib active pharmaceutical ingredient manufacture and distribution are subject to stringent requirements because of the strong regulatory frameworks. Furthermore, rheumatoid arthritis and osteoarthritis, two chronic inflammatory disorders, are becoming more common worldwide, particularly among the elderly. The need for standard-grade celecoxib API is being driven up by the growing need for safe and effective anti-inflammatory drugs, which is being driven up by this demographic trend, fueling the expansion of the market.
The pharmaceutical industry is growing because chronic inflammatory illnesses are becoming more common. In addition, this market segment is growing at a rapid pace due to the global aging population. Moreover, the pharmaceutical section of the celecoxib API market is expected to rise due to continuing research and development efforts that are investigating potential new therapeutic uses of celecoxib in different medical conditions.
The North American celecoxib API market is expected to register the highest market share in revenue in the near future. It can be attributed to the high prevalence of arthritis and other chronic pain-related ailments in the region, which necessitates the development of effective drugs to manage inflammation and an older population that is more prone to these illnesses. In addition, Asia Pacific is projected to grow rapidly in the global celecoxib API market because of a highly developed healthcare system, substantial healthcare spending, a thriving pharmaceutical industry, generic medication makers, and a strict regulatory environment.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 58.9 Mn |
|
Revenue Forecast In 2031 |
USD 87.0 Mn |
|
Growth Rate CAGR |
CAGR of 5.1% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, By Application and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Pfizer, Teva Pharmaceuticals, Viatris, ScinoPharm, Jiangxi Synergy, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, Hisun Pharmaceutical Nantong, Aurobindo Pharma, and Punjab Chemicals. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Celecoxib API Market Snapshot
Chapter 4. Global Celecoxib API Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Standard grade Celecoxib API
5.2.2. Micronized Celecoxib API
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Pharmaceutical
6.2.2. Laboratory
Chapter 7. Celecoxib API Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.1.2. North America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.1.3. North America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.2. Europe
7.2.1. Europe Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.2.2. Europe Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.2.3. Europe Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.3.2. Asia Pacific Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.3.3. Asia Pacific Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.4. Latin America
7.4.1. Latin America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.4.2. Latin America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.4.3. Latin America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.5.2. Middle East & Africa Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.5.3. Middle East & Africa Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Pfizer (U.S.)
8.2.2. Teva Pharmaceuticals (Israel)
8.2.3. Viatris (U.S.)
8.2.4. ScinoPharm (China)
8.2.5. Jiangxi Synergy (China)
8.2.6. Jiangsu Hengrui Medicine (China)
8.2.7. Jiangsu Chiatai Qingjiang (China)
8.2.8. Hisun Pharmaceutical Nantong (China)
8.2.9. Aurobindo Pharma (India)
8.2.10. Punjab Chemicals (India)
8.2.11. Other Prominent Players
Celecoxib API Market- By Type
Celecoxib API Market- By Application
Celecoxib API Market- By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
